AUSTIN, Texas, May 11 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has treated more than 2,300 patients with heart rhythm disorders since it launched on May 1, 2008 -- about a fourth of them from outside Central Texas.
"In just one year, the physician team at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, coupled with our unmatched level of technology, has drawn thousands of patients for the advanced treatment of heart rhythm disorders," C. David Huffstutler, Chief Executive Officer of St. David's Medical Center, said. "It's a level of comprehensive treatment they cannot get anywhere else in the country."
Led by world-renowned electrophysiologist, Andrea Natale, M.D., F.A.C.C., F.H.R.S., TCAI is the first center of its kind in the U.S. devoted to curing Atrial Fibrillation (A Fib), a heart rhythm disorder known as the "silent killer" because it can cause a massive stroke with no warning.
In addition to drawing a regional patient base, TCAI -- a multimillion-dollar international treatment, training and research center that specializes in heart rhythm disorders -- has also achieved several "firsts" during its first year of operation. Physicians at TCAI have served as pioneers in innovative treatment techniques and technology, and made extraordinary strides in physician training and clinical research related to heart rhythm disorders.
On March 3, 2009, physicians at TCAI were the first in the nation to use a new technology, the NaviStar(R) RMT ThermoCool(R) Catheter for radiofrequency (RF) ablation, to treat A Fib. TCAI was the first facility in the country to use the technology after it was approved by the FDA.
Two TCAI physicians traveled to Poland in January 2009 to pioneer a new procedure to treat A Fib.
Then, on March 4, those two physicians, Rodney P. Horton, M.D., electrophysiologist
|SOURCE Texas Cardiac Arrhythmia Institute|
Copyright©2009 PR Newswire.
All rights reserved